Dr. Christine Allen

CEO & Co-founder, Professor · Intrepid Labs Inc., University of Toronto · company speakers →

In this keynote, Dr. Christine Allen will share a practical vision for the future of bio/pharma: a digital-by-design approach to drug development where experiments, decisions, and supply chains are connected through a modern data backbone. She will explore how AI, high-throughput automation, and cloud-native infrastructure can expand the formulation and process design space while addressing what matters from the start, including patient experience, manufacturability, cost-per-dose, and supplier resilience across regions. Drawing on lessons from integrating AI into established development workflows, she will highlight what makes digital transformation durable: tools designed with domain experts, transparent trade-offs, and human-in-the-loop decision support that strengthens scientific judgment. The talk will also touch on how these approaches can identify critical issues earlier and strengthen the path from development to commercialization.

Is this you? Claim this profile →